Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Extends Juvaderm's Scope - Happi
Company News

FDA Extends Juvaderm’s Scope

Allergan's injectable OK'd for lip area.

Allergan plc, has received approval from the U.S. FDA to market Juvederm Ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.
 
“As the leader in medical aesthetics, Allergan is committed to continued research and development in this area,” said Philippe Schaison, EVP & president, Allergan Medical. “With this approval, Juvederm Ultra XC is now the only filler that is approved to last up to one year in the lips while providing natural-looking results.”
 
Juvederm formulations were first approved in the US in 2006.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters